Russia’s Gamaleya Prepared All Necessary Papers on Sputnik V for EMA Representatives

Apr 5, 2021 | EARNINGS

MOSCOW (Sputnik) – Russia’s Gamaleya research institute, which developed the Sputnik V vaccine against the coronavirus, is getting ready for the upcoming visit of the European Medicines Agency (EMA) representatives, it has already prepared the set of documents related to the vaccine, institute chief Alexander Gintsburg told Sputnik.

Read More

Pin It on Pinterest